Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Opus Genetics, Inc. (NASDAQ: IRD)
IRD Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
1.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
133.60%
IRD Stock Analysis
IRD
PE Ratio:
IRD
PEG Ratio:
Not Available
IRD
Forward EPS Growth (12 month):
0.00%
IRD
PS Ratio:
27.8
IRD
PSG Ratio:
1.9
IRD
Forward Revenue Growth (12 month):
14.40%
IRD Articles
No data was found